ResearcherWestlake UniversityActive in the last 2 years

Jianfeng Yang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101648412. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial cells changes. Co-author DOI 10.1016/j.jep.2024.118711 ↗
Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic cancer. Co-author DOI 10.4103/eus-d-21-00013 ↗
Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Co-author DOI 10.3892/mmr.2018.8763 ↗
Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling. Co-author DOI 10.3892/ol.2018.9455 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaofeng Zhang · 2 shared papers, 2021–2025 · strength 0.47
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
- Paper Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic … DOI 10.4103/eus-d-21-00013 ↗
Hangbin Jin · 2 shared papers, 2018–2025 · strength 0.38
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
- Paper Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of ep… DOI 10.3892/mmr.2018.8763 ↗
Yu Wang · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
Yan Chen · 1 shared paper, 2025 · strength 0.28
- Paper Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial… DOI 10.1016/j.jep.2024.118711 ↗
Shenglin Ma · 2 shared papers, 2018 · strength 0.20
- Paper Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling. DOI 10.3892/ol.2018.9455 ↗
- Paper Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of ep… DOI 10.3892/mmr.2018.8763 ↗
Qifeng Lou · 1 shared paper, 2021 · strength 0.19
- Paper Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic … DOI 10.4103/eus-d-21-00013 ↗
Hangbin Jin · 1 shared paper, 2018 · strength 0.11
- Paper Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling. DOI 10.3892/ol.2018.9455 ↗
Shirong Zhang · 1 shared paper, 2018 · strength 0.10
- Paper Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of ep… DOI 10.3892/mmr.2018.8763 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.